Navigation Links
MBC in Medical News

Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009

... Breast Cancer: Investigational data on new biomarkers in TYKERB(R)/TYVERB(R) (lapatinib) based treatment. "cMET expression in Her2+ mbc patients with first-line lapatinib (L) treatment." Dr. Y. Liu, GlaxoSmithKline, Collegeville, PA; Poster presentation on June 1. "Clinical ben...

US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium

... HER2-positive MBC. The study's investigators concluded that T-DM1 has single agent activity in patients with previously-treated HER2-positive mbc and appears to have anti-tumor activity in trastuzumab and lapatinib-pretreated patients. T-DM1 also appears to be well tolerated at the dose and sche...

New Survey Underscores Importance of Psychosocial and Educational Needs Among Women with Advanced Breast Cancer

... patients. The survey uncovered that patients with mbc feel that the Internet can be utilized more effect...heir doctors (42%), and 86 percent said Web- based mbc education and support materials would be most help...; 36% disagreed with the statement that women with mbc have a variety of treatment options available to t...

Survey underscores importance of emotional/educational needs among women with advanced breast cancer

...patients. The survey uncovered that patients with mbc feel that the Internet can be utilized more effect...ents said they get most of their information about mbc from the Internet (39%) as from their doctors (42%), and 86 percent said Web-based mbc education and support materials would be most help...

Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Council's Ninth Annual MASS Opportunities Investment Conference

...s the nation's oldest biotechnology trade association. Founded in 1985, the mbc is a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry. The mbc is committed to advancing the development of critical new science, technolo...

Mayor's Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City

...estimated that there are 150,000 women living with mbc in the U.S. The Metastatic Breast Cancer Conferen...r disease. We hope the women of New York City with mbc will come out on October 13 to learn about them." ..., author of the play Tough Titty and New York City mbc patient. "I'm glad we have conferences like the MB...
MBC in Medical Technology

Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy

...d at ESMO investigated the safety and tolerability of increasing doses of adecatumumab in combination with standard chemotherapy docetaxel in relapsed mbc patients who had a median of three prior chemotherapy regimens. Combining adecatumumab with docetaxel appears to be feasible with clinically manageabl...

Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)

...ycin-susceptible isolates, the cethromycin MIC and mbc ranges were < / = 0.002-0.008 mg/L, compared with the MIC range of < / = 0.002-0.25 mg/L and mbc range of < / = 0.002-1.0 mg/L obtained with the er...and clindamycin, against which cethromycin MIC and mbc ranges were < / = 0.002-0.06 mg/L. David A. Eizn...

US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings

...er (MBC) is progressing in spite of trastuzumab therapy," said Dr. O'Shaughnessy. "This combination is an important new therapeutic strategy for HER2+ mbc patients, one that does not contain chemotherapy. This combination also has exciting potential as treatment for early stage breast cancer, a hypothesi...

OncoGenex Technologies Announces Phase II Data of OGX-011 in Metastatic Breast Cancer at American Association for Cancer Research 2007 Annual Meeting

... well tolerated in combination with docetaxel. Women with measurable metastatic breast cancer and no more than one previous chemotherapy regimen for mbc were eligible for this study. OGX-011 was delivered three times at 640 mg intravenously as a loading phase prior to initiating chemotherapy. The loadi...

Lilly Studies Try to Shed Light on Impact of Race on Lung Cancer Treatment

...periodically thereafter. Adverse Events The most severe adverse events (grades 3/4) with GEMZAR plus paclitaxel for the treatment of patients with mbc were neutropenia (48%); alopecia (18%); leukopenia (11%); anemia (7%); fatigue (7%); thrombocytopenia (6%); ALT elevation (6%); and neuropathy-sensory...
MBC in Biological News

Snapin: A protein with therapy potential for autism

...in therapies aimed at learning and memory disorders. The article will appear in the journal Molecular Biology of the Cell but appeared online today at mbc in Press ( www.molbiolcell.org/in_press.shtml ). While disorders like autism may arise from a multiplicity of causes, research at the cellular leve...
MBC in Biological Technology

Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer

...ted tomography (FDG-PET/CT), predicted survival in mbc patients on standard therapies. The comparison sho...th technologies significantly correlate to overall mbc patient survival (p<0.001 for CTCs and p=0.001 ...could better predict the prognosis and survival in mbc patients. The CellSearch(R) System is the fi...

Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel

...d chemotherapy docetaxel (Taxotere(R)) in relapsed mbc patients who had a median of three prior chemother...al investigating adecatumumab as a single agent in mbc patients that also suggested that treatment with a...taxanes could be a valuable development option for mbc patients with high EpCAM expression on their tumor...

Sopherion Therapeutics, LLC Announces Publication of Phase I/II Myocet(R) (Nonpegylated Liposomal Doxorubicin) Data in Advanced Breast Cancer Patients

...ed, 15 in the dose escalating part and 54 at the recommended phase II dose. Women with measurable, previously untreated, HER-2-overexpressing LABC and mbc - and a baseline left ventricular ejection fraction (LVEF) > 50 percent - received weekly trastuzumab in combination with escalating doses of weekl...

BioSpace and the Massachusetts Biotechnology Council Inc. Launch 2009 Genetown&#8482; Hotbed Campaign

...Space. "With the support and participation of mbc for more than a decade, the 2009 Genetown Hotbed M...Biotechnology Council (MBC): Founded in 1985, the mbc is the nation's oldest biotechnology trade associa...dicated to growing biotechnology in Massachusetts. mbc is online at www.massbio.org . Contact: onT...

EntreMed Announces 2008 Corporate and Clinical Program Priorities

...cers, ovarian and endometrial cancer, and pancreatic cancer. Milestones for MKC-1 in 2008 include reporting results for the single agent MKC-1 mbc study (2Q08); presentation of interim data for MKC-1/Alimta combination study in NSCLC (2Q08); presentation of Phase 1 data for MKC-1 in hemat...

BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown(TM) Hotbed Campaign

...n," said Wes Crews, CEO of BioSpace. "With the support and participation of mbc and our sponsors, Thermo Fisher Scientific and Wyeth Biotech, the 2008 Gene...ides services and support for the Massachusetts biotechnology industry. The mbc is committed to advancing the development of critical new science, technolo...

2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies

...s the nation's oldest biotechnology trade association. Founded in 1985, the mbc is a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry. The mbc is committed to advancing the development of critical new science, technolo...
Other Tags
(Date:1/22/2015)... The City of West Hollywood hosted a news conference ... 42nd anniversary of the Supreme Court decision Roe v. Wade, which ... since the Roe vs. Wade decision and the fight to protect ... said City of West Hollywood Councilmember Abbe Land. “We need to ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together by ... up to 30lbs in less than 12 weeks without traditional ... prompting an investigative review. , “Our Incredible Bulk review ... that allows the body to pack on a massive amount ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 Juvent ... today at the 2015 PGA Merchandise Show to bestow ... and incredible female amateur golfer, Arlene McKitrick. The award ... female amateur golf tournament win. She won her first ...
(Date:1/22/2015)... Carinsurancesavings.biz has released a new blog post presenting the basic ... , Purchasing an accidental death and dismemberment rider for a ... rider provides benefits if the insured dies in an accident. ... of life insurance. , AD&D is not expensive and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ) ... Wearable Technologies Market and Applications, Opportunities, Industry Analysis, ... 2014-2020" report to their offering. , ... can be worn on the user,s body and ...
(Date:12/22/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/fx4bg3/the_global ... "The Global Watermarking and Fingerprinting Markets" report ... http://photos.prnewswire.com/prnh/20130307/600769 This insight provides an ... fingerprinting markets. Watermarking aims to control and monitor ...
(Date:12/19/2014)... LaunchKey , the first decentralized mobile authentication and authorization ... era, today announced the close of $3 million in ... Metamorphic Ventures with participation from ENIAC Ventures, Crosslink Capital, ... has raised $4 million to date, and will use ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
Other Contents